MedPath

Bridging Pharma GmbH

🇨🇭Switzerland
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

NMPA:7

Drug Approvals

Mucopolysaccharide Polysulfate Cream

Product Name
喜辽妥
Approval Number
国药准字HJ20160602
Approval Date
Jun 28, 2024
NMPA

Mucopolysaccharide Polysulfate Cream

Product Name
喜辽妥
Approval Number
国药准字HJ20160601
Approval Date
Jun 28, 2024
NMPA

Oryz-Aspergillus Enzyme And Pancreatin Tablet

Product Name
慷彼申
Approval Number
国药准字HJ20170092
Approval Date
Jun 21, 2021
NMPA

Oryz-Aspergillus Enzyme And Pancreatin Tablet

Product Name
慷彼申
Approval Number
国药准字HJ20191029
Approval Date
Jun 21, 2021
NMPA

Bromocriptine Mesilate Tablets

Product Name
Parlodel
Approval Number
国药准字HJ20160030
Approval Date
Jan 13, 2021
NMPA

Mucopolysaccharide Polysulfate Cream

Product Name
喜辽妥
Approval Number
H20160602
Approval Date
Dec 6, 2019
NMPA

Mucopolysaccharide Polysulfate Cream

Product Name
喜辽妥
Approval Number
H20160601
Approval Date
Dec 6, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.